See also: Statin dose equivalency chart

 

Source: https://www.uspharmacist.com/article/statin-associated-myopathy

---

"Tables 6–8 compares events (all myopathy codes) across classes of statins and fibrates, based on different exposure times, applying the same exclusion criteria. At 26 weeks exposure, the greatest risks for myopathy are with fluvastatin RR 33.3 (95% CI 16.8–66.0) and ciprofibrate RR (40.5 95% CI 13.4–122.0)."

Source: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002522

 

Content on this page has not been checked for accuracy. The author's credentials have not been confirmed. Always use multiple peer-reviewed scholarly sources and good clinical judgement in your decision making.

The Compendium platform was created by David Kwinter, MD, CCFP(EM).